The aim is to compare the diagnostic performance of PSMA PET-CT and choline PET-CT for high-risk localized prostate cancer.
Assess diagnostic performance of both imaging techniques
Evaluate clinical implications for treatment decisions
Compare efficacy in detecting high-risk prostate cancer
PSMA PET-CT shows superior diagnostic capabilities compared to choline PET-CT
Improved accuracy is reported in identifying prostate cancer
Clinical decision-making is positively influenced by PSMA PET-CT results
Abstract
PSMA PET-CT offers superior diagnostic performance to choline PET-CT in patients with high-risk prostate cancer which has a clinical impact on therapeutic decision-making.
AI에게 질문
Like
Bookmark
Share
View Full Paper
Cite This Study
Tárraga-Honrubia et al. (Tue,) studied this question.